This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Cost-effectiveness of HAART underestimated

February 14th, 2012

Bohdan Nosyk and Julio Montaner of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, Canada argue in an Essay published in this week's PLoS Medicine that the cost-effectiveness of HAART roll out has been significantly underestimated, because economic analyses have not yet taken into account the beneficial impact of HAART on prevention of HIV transmission.

The authors comment: "the strategic value of expanded HIV testing and expansion of HAART coverage has dramatically increased. We believe this should open the door for wide-scale implementation of ''Seek, Test, Treat and Retain'' programs as a means to control HIV and AIDS-related morbidity, mortality, and transmission at once."

More information:
Nosyk B, Montaner JSG (2012) The Evolving Landscape of the Economics of HIV Treatment and Prevention. PLoS Med 9(2): e1001174. doi:10.1371/journal.pmed.1001174

Provided by Public Library of Science

Citation: Cost-effectiveness of HAART underestimated (2012, February 14) retrieved 8 August 2026 from https://sciencex.com/wire-news/90700639/cost-effectiveness-of-haart-underestimated.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.